- Clinical Trials
- May 2026
- 60 Pages
Global
From €1118EUR$1,250USD£958GBP
- Drug Pipelines
- April 2026
- 280 Pages
Global
From €2684EUR$3,000USD£2,299GBP
- Report
- April 2026
- 30 Pages
Global
From €2460EUR$2,750USD£2,108GBP
- Clinical Trials
- April 2026
- 450 Pages
Global
From €4473EUR$5,000USD£3,832GBP
- Clinical Trials
- April 2026
- 180 Pages
Global
From €1789EUR$2,000USD£1,533GBP
- Report
- July 2026
- 100 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Report
- April 2026
- 180 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Report
- May 2026
- 100 Pages
Global
From €2414EUR$2,699USD£2,069GBP
- Report
- May 2026
- 100 Pages
Global
From €2414EUR$2,699USD£2,069GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2495EUR$2,789USD£2,138GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2495EUR$2,789USD£2,138GBP
- Report
- May 2026
- 200 Pages
Global
From €2495EUR$2,789USD£2,138GBP
- Report
- March 2026
- 400 Pages
Global
From €4427EUR$4,949USD£3,793GBP
- Report
- March 2026
- 150 Pages
Global
From €2414EUR$2,699USD£2,069GBP
- Report
- July 2026
- 120 Pages
Global
From €4249EUR$4,750USD£3,641GBP
- Report
- April 2026
- 305 Pages
Global
From €2236EUR$2,500USD£1,916GBP
- Report
- January 2026
- 286 Pages
Global
From €2236EUR$2,500USD£1,916GBP
- Report
- September 2026
- 150 Pages
Global
From €3355EUR$3,750USD£2,874GBP
- Report
- September 2026
- 150 Pages
Global
From €3355EUR$3,750USD£2,874GBP
- Report
- March 2026
- 150 Pages
Global
From €3355EUR$3,750USD£2,874GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more